Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex
PMA-S includes submission for pathogen-reduced cryoprecipitate-poor plasma CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq:CERS) announced today that…
Sola Security Launches Lumina, an Autonomous Security Deep Research Platform for Actionable Risk Intelligence